AROCELL AB UPPSALA ALLPF news, videos and press releases
For more news please use our advanced search feature.
AROCELL AB UPPSALA ALLPF - More news...
AROCELL AB UPPSALA ALLPF - More news...
- Thymidine Kinase 1 can be used for early detection of therapy response in breast cancer treatment
- AroCell expands with a Regulatory Affairs Director
- AroCell AB (publ) Interim Report January 1st to June 30th 2019
- AroCell AB (publ) Interim Report 1st January to 31st March 2019
- AroCell establish a Scientific Advisory Board
- CORRECTED VERSION of March 20, 2019 Press Release: New scientific publication from AroCell on TK 210 ELISA in prostate cancer
- New scientific publication from AroCell on TK 210 ELISA in prostate cancer
- Abstract from AroCell accepted for poster presentation during AACR 2019
- New study results with AroCell TK 210 ELISA in prostate cancer has been accepted for publication
- AroCell AB (publ) Year-End Report 2018
- AroCell launches new website
- AroCell signs distribution agreement with Gongyingshi in China for AroCell TK 210 ELISA
- AroCell signs distribution agreement with Eurobio Scientific in France
- A new scientific publication from AroCell confirming the value of AroCell TK 210 ELISA as a tool in drug discovery and development
- Patent granted in the US
- A second abstract accepted at ISOBM in Hamburg demonstrating enhanced diagnostic value when using AroCell’s proprietary sample preparation method
- A new study comparing TK 210™ ELISA from AroCell with other activity-based assays for the measurement of TK1 in serum shows high correlation between methods when samples from subjects with hematological malignancies are compared. The study
